The effect of the “Ghors-e-Vard” ?on functional dyspepsia

Evaluation of the effect of the traditional poly-herbal preparation, “Ghors-e-Vard”, ?on clinical symptoms of patients with functional dyspepsia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200128046291N1

Enrollment

Registered

2020-03-09

Start date

2020-04-03

Completion date

Unknown

Last updated

2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia.

Interventions

Intervention 1: Intervention group: 35 patients with functional dyspepsia take 30 capsules of "Ghorse- vard" 3 times a day for 30 days after a meal. For small-lab-scale preparation of Ghors-Vard, in t

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients with Functional dyspepsia Ages 18 to 65 years

Exclusion criteria

Exclusion criteria: History of gastrointestinal ulcer or reflux disease with natural endoscopy with no specific pathologic findings, Underlying diseases including heart failure, hypertension, renal failure and uremic disease, cirrhosis History of abdominal surgery Any malignancy NSAIDs Use Having a history of chemotherapy and radiotherapy or exposure to radioactive radiation. Use of any other herbal medicine Pregnancy and lactation Positive urea breath test for Helicobacter pylori infection

Design outcomes

Primary

Measure	Time frame
Changes in clinical symptoms of functional dyspepcia. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).	—

Secondary

Measure	Time frame
Epigastric pain. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Heart burn. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Early satiety. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Feeling fullness after meals. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Nausea. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Burp. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Flatulence. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale(GSRS).;Quality of Life. Timepoint: In days 0,30. Method of measurement: Quality of Life Questionnaire (SF36).	—

Measure

Time frame

Epigastric pain. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Heart burn. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Early satiety. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Feeling fullness after meals. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Nausea. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Burp. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale (GSRS).;Flatulence. Timepoint: In days 0,14,30,60. Method of measurement: Gastrointestinal Symptom Rating Scale(GSRS).;Quality of Life. Timepoint: In days 0,30. Method of measurement: Quality of Life Questionnaire (SF36).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Kerdarian

Babol University of Medical Sciences

Hosseinkerdarian@yahoo.com+98 11 3219 9592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026